Connect with us

Technology

Ecommerce Marketing Study: How American Brands Made $1.4 Billion in 2024

Published

on

Omnisend’s analysis of more than 11 billion marketing messages sent by American brands has revealed:

American brands made $1.4 billion in revenue from 8.5 million sales, setting the average order value (AOV) for 2024 at $165.Brands sent 2.5 times more push notifications and 43% more SMS in 2024 than they did in 2023. In total, the adoption of these two channels has grown by 68% year-over-year.1 in 3 people who click on an automated message make a purchase, compared to 1 in 17 for regular, scheduled messages.Automated emails drove 29% of sales, though they represented just 1.5% of email volume. The same trend was noticed with SMS and push notifications campaigns where the ratio was 18% to 7.5%, and 21% to 4%, respectively.The top industries for email marketing click-to-conversion rate in the U.S. were Health (13.44%), Games (12.43%).

CHARLESTON, S.C., Jan. 27, 2025 /PRNewswire/ — Omnisend, a leading ecommerce marketing platform, has released its annual ecommerce marketing study, revealing how American brands used 11 billion emails, 172 million SMS, and 87 million push notifications to drive $1.4 billion in revenue from 8.5 million sales in 2024.

“Algorithms change. Data shares stop. As seen with TikTok, platforms get banned. Relying on third-party channels makes brands vulnerable. First-party channels, on the other hand, leave brands in control of their customer engagement, making them critical for growing sales,” says Greg Zakowicz, Sr. Ecommerce Expert at Omnisend.

The report underscores the growing importance of SMS and push notifications as essential tools for ecommerce marketing. With adoption up 68% year-over-year, these channels are proving to be highly effective for driving customer engagement.

“It’s no surprise SMS continues to grow and deliver results. As a ubiquitous channel spanning all generations, and a primary one for many, its adoption for brand communications was inevitable as text-first habits became the norm,” says Zakowicz.

“Web push messages are growing due to increased awareness and brands exploring less competitive channels. Unlike crowded, costly platforms like social and paid search, web push offers an inexpensive way to engage and convert shoppers.”

1 in 3 people who click on an automated message make a purchase

Automated emails1 drove 29% of sales, though they represented just 1.5% of email volume. The same trend was noticed with SMS and push notifications campaigns where the ratio was 18% to 7.5%, and 21% to 4%, respectively.

“If brands have been neglecting automated messages to this point, they need to stop. The right automated messages are the cheat code to increase both first-time and repeat sales,” says Zakowicz.

The best performing email automations in 2024 were:

“Back in stock” – 60.43% open rate; 5.89% conversion rate.”Abandoned cart” – 49.04% open rate; 2.34% conversion rate.”Welcome” – 32.43% open rate; 1.48% conversion rate.

“Back-in-stock emails continue to dominate in terms of open, click, and conversion rates. These messages are a form of social proof – they sold out once and people loved them – and naturally convey a sense of FOMO that generates sales,” says Zakowicz.

Health and Games were the best performing industries for email marketing

Health led 2024 with the highest click-to-conversion rate at 13.44%, followed by Games at 12.43%. Health remains the highest converting industry for three years in a row.

Brands in the Apparel industry had one of the highest open rates with a 36.46% average. However, the percentage of people who opened an email and clicked on a link was the lowest across industries.

“For Apparel brands the challenge lies in converting attention into action. Brands should spend time optimizing their email templates by incorporating more social proof, such as customer reviews and enhancing product images to make them more appealing,” says Zakowicz.

How can brands improve their marketing strategy for 2025?

To make your marketing budget go further, Zakowicz recommends:

Use Behavior-Triggered Messaging. Use data to identify customer behavior patterns and send tailored automated messages at key moments, such as post-purchase follow-ups or product recommendations. Personalization based on real-time actions drives significantly better engagement and conversion rates.Diversify with SMS and Push Notifications. Combine email, SMS, and push notifications to create multi-touchpoint customer journeys. For example, use SMS for immediate alerts like flash sales, email for detailed product showcases, and push notifications for last-minute cart reminders.Leverage Social Proof and Scarcity Tactics. Incorporate elements like customer reviews, back-in-stock alerts, and low-stock notices in your messaging. These tactics tap into FOMO and build trust, encouraging quicker purchasing decisions.Analyze and Refine Regularly. Track metrics like open rates, click rates, and conversion rates for each channel. Use these insights to refine your strategies, focusing on what drives the most value for your specific audience.

Find out more here: https://www.omnisend.com/2025-ecommerce-marketing-report

1 Automated emails are messages triggered by user behavior, such as when a user abandons a cart, subscribes to a newsletter, or makes a purchase.

Methodology

This report analyzed close to 24 billion marketing emails, 230 million SMS, and 413 million web push messages sent by Omnisend merchants in 2024 worldwide. We calculated conversion rates by looking at attributed orders compared to total emails/SMS/push messages sent and calculated click rates by looking at the number of clicks compared to the number of emails/SMS/push messages sent.

We also use the following terminology:

Scheduled campaigns (campaigns): messages manually sent by brands, such as those promoting special offers, discounts, new products, and other promotional-style messages.Automated messages (automations): automated messages triggered by user behavior, such as when a user abandons a cart, subscribes to a newsletter, or makes a purchase.

About Omnisend

Omnisend is an email & SMS marketing platform with a suite of features made specifically to help ecommerce stores grow their online businesses faster. One-click integration with major ecommerce platforms, pre-made automation & email templates, and award-winning 24/7/365 live customer support make it easy for brands of any size to sell more—all without the exaggerated cost.

“Great marketing needs to be expensive” is a myth that 125,000+ Omnisend customers are busting every day by growing their businesses with email and SMS marketing.

For further information, please contact:

Matas Duda, PR Specialist, matas.d@omnisend.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ecommerce-marketing-study-how-american-brands-made-1-4-billion-in-2024–302360975.html

SOURCE Omnisend

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending